DEFINING THE ROLES OF SGLT2IS AND GLP-1 RAS IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES AND/OR OVERWEIGHT/OBESITY: A DELPHI CONSENSUS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/78cd053aa7fd9f44f41fdfe11dc51bb9.pdf
DEFINING THE ROLES OF SGLT2IS AND GLP-1 RAS IN THE MANAGEMENT OF CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES AND/OR OVERWEIGHT/OBESITY: A DELPHI CONSENSUS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Peter
Rossing
Yehuda Handelsman yhandelsman@gmail.com Metabolic Institute of America NA Los Angeles United States -
Alice YY Cheng Alice.Cheng@unityhealth.to University of Toronto Department of Medicine Toronto Canada -
Gian Paolo Fadini gianpaolofadini@hotmail.com University of Padova Department of Medicine Padua Italy -
Pam Kushner pamkushner@hotmail.com University of California Irvine Medical Center Department of Family Medicine Orange United States -
Fabrice Bonnet fabrice.bonnet@chu-rennes.fr University of Rennes Department of Diabetes Rennes France -
Paola Fioretto paola.fioretto@unipd.it University of Padova Department of Medicine Padua Italy -
Takashi Kadowaki t-kadowaki@toranomon.kkr.or.jp Toranomon Hospital Department of Diabetes and Metabolic Diseases Tokyo Japan -
Naresh Kanumilli nkanumilli@nhs.net Northenden Group Practice General Practice Wythenshawe United Kingdom -
Xavier Cos xavier.cos@gencat.cat IDIAP Jordi Gol, Institut Català de la Salut CIBERDEM Barcelona Spain -
Thomas Frese thomas.frese@uk-halle.de Institute of General Practice and Family Medicine, Interdisciplinary Center of Health Sciences Medical Faculty, Martin-Luther-University Halle-Wittenberg Halle / Saale Germany -
Linong Ji jiln@bjmu.edu.cn Peking University People’s Hospital Department of Internal Medicine Beijing China -
Peter Rossing peter.rossing@regionh.dk University of Copenhagen Department of Clinical Medicine, Internal Medicine, Endocrinology Copenhagen Denmark *